Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer

This study has been completed.
Information provided by:
Speciality European Pharma Limited Identifier:
First received: February 10, 2009
Last updated: NA
Last verified: February 2009
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2003
  Primary Completion Date: February 2001 (Final data collection date for primary outcome measure)